Bayer AG, in collaboration with BlueRock Therapeutics, is conducting a Phase 3 study titled ‘exPDite-2’ to evaluate the efficacy and safety of bemdaneprocel, a midbrain dopaminergic neuronal cell ...
A new study sheds new light on these big questions, illuminating a general principle of neural processing in a mysterious region of the midbrain that is the very origin of our central serotonin (5-HT) ...
Using a ChatGPT-like AI model, scientists have created a new map of the mouse brain that captures previously uncharted areas ...